Bonavida B - Search Results

1

Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.

Eptaminitaki GC, Stellas D, Bonavida B, Baritaki S. Eptaminitaki GC, et al. Among authors: bonavida b. Drug Resist Updat. 2022 Dec;65:100866. doi: 10.1016/j.drup.2022.100866. Epub 2022 Sep 20. Drug Resist Updat. 2022. PMID: 36198236 Review.

2

Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma.

Bonavida B, Vega MI. Bonavida B, et al. Drug Resist Updat. 2005 Feb-Apr;8(1-2):27-41. doi: 10.1016/j.drup.2005.02.004. Epub 2005 Apr 8. Drug Resist Updat. 2005. PMID: 15939340 Review.

3

Therapeutic potential of nitric oxide in cancer.

Bonavida B, Khineche S, Huerta-Yepez S, Garbán H. Bonavida B, et al. Drug Resist Updat. 2006 Jun;9(3):157-73. doi: 10.1016/j.drup.2006.05.003. Epub 2006 Jul 5. Drug Resist Updat. 2006. PMID: 16822706 Review.

4

Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agent.

Katsman A, Umezawa K, Bonavida B. Katsman A, et al. Among authors: bonavida b. Drug Resist Updat. 2007 Feb-Apr;10(1-2):1-12. doi: 10.1016/j.drup.2007.01.002. Epub 2007 Feb 15. Drug Resist Updat. 2007. PMID: 17306602 Review.

5

Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth.

Chen H, Gordon MS, Campbell RA, Li M, Wang CS, Lee HJ, Sanchez E, Manyak SJ, Gui D, Shalitin D, Said J, Chang Y, Deuel TF, Baritaki S, Bonavida B, Berenson JR. Chen H, et al. Among authors: bonavida b. Blood. 2007 Jul 1;110(1):287-95. doi: 10.1182/blood-2006-08-042374. Epub 2007 Mar 16. Blood. 2007. PMID: 17369488 Free article.

6

Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.

Baritaki S, Huerta-Yepez S, Sakai T, Spandidos DA, Bonavida B. Baritaki S, et al. Among authors: bonavida b. Mol Cancer Ther. 2007 Apr;6(4):1387-99. doi: 10.1158/1535-7163.MCT-06-0521. Mol Cancer Ther. 2007. PMID: 17431117

7

Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications.

Baritaki S, Apostolakis S, Kanellou P, Dimanche-Boitrel MT, Spandidos DA, Bonavida B. Baritaki S, et al. Among authors: bonavida b. Adv Cancer Res. 2007;98:149-90. doi: 10.1016/S0065-230X(06)98005-1. Adv Cancer Res. 2007. PMID: 17433910 Review.

8

Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection.

Baritaki S, Sifakis S, Huerta-Yepez S, Neonakis IK, Soufla G, Bonavida B, Spandidos DA. Baritaki S, et al. Among authors: bonavida b. Int J Oncol. 2007 Jul;31(1):69-79. Int J Oncol. 2007. PMID: 17549406

9

Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid.

Campbell RA, Sanchez E, Steinberg JA, Baritaki S, Gordon M, Wang C, Shalitin D, Chen H, Pang S, Bonavida B, Said J, Berenson JR. Campbell RA, et al. Among authors: bonavida b. Br J Haematol. 2007 Aug;138(4):467-78. doi: 10.1111/j.1365-2141.2007.06675.x. Epub 2007 Jun 22. Br J Haematol. 2007. PMID: 17587338 Free article.

10

The NO TRAIL to YES TRAIL in cancer therapy (review).

Lee JY, Huerta-Yepez S, Vega M, Baritaki S, Spandidos DA, Bonavida B. Lee JY, et al. Among authors: bonavida b. Int J Oncol. 2007 Oct;31(4):685-91. Int J Oncol. 2007. PMID: 17786298 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

459 results

Search Page